PALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., the leading technology provider for modern clinical trials, today announced that Medable CEO and Co-Founder Michelle Longmire will be presenting a corporate update at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. The presentation will take place on Wednesday, January 15, 2025, at 4:30 pm Pacific Time (7:30 pm Eastern Time). About Medable Medable is revolutionizing clinical drug development with its Software as a Service (Sa
Medable is a California-based decentralized clinical trial platform that delivers solutions such as patient monitoring and DCT screening for the healthcare sector.